Cargando…
Drug‐induced liver injury by glatiramer acetate leading to liver transplant: A case report
Glatiramer acetate (GA) is a widely used immune‐modulating drug in relapsing multiple sclerosis (MS). Although a few cases of drug‐induced liver injury during GA therapy have been reported earlier, herein we present the case of a 43‐year‐old woman with relapsing MS who experienced acute liver failur...
Autores principales: | Amirkhani, Nikan, Khalaji, Amirmohammad, Alehossein, Parsa, Safaei, Masoomeh, Aletaha, Najme, Miroliaee, Arash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Publishing Asia Pty Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463015/ https://www.ncbi.nlm.nih.gov/pubmed/37649866 http://dx.doi.org/10.1002/jgh3.12938 |
Ejemplares similares
-
Liver injury and glatiramer acetate, an uncommon association: case report and literature review
por: Almeida, Javier, et al.
Publicado: (2017) -
High circulating endocan in chronic kidney disease? A systematic review and meta-analysis
por: Khalaji, Amirmohammad, et al.
Publicado: (2023) -
Chemerin levels in chronic kidney disease: A systematic review and meta-analysis
por: Behnoush, Amir Hossein, et al.
Publicado: (2023) -
Drug-Induced Liver Injury by Glatiramer Acetate Used for Treatment of Multiple Sclerosis: A Case Report
por: Onmez, Attila, et al.
Publicado: (2013) -
Follow-on glatiramer acetate
por: Cohen, Jeffrey A., et al.
Publicado: (2018)